Cargando…
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies
SIMPLE SUMMARY: Estrogen receptor-positive (ER+) breast cancer is a notable cause of global death from breast cancer in premenopausal and postmenopausal women. Lethality is driven, amongst other things, by endocrine resistance, which is intrinsic or acquired in approximately 60% of patients after an...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655708/ https://www.ncbi.nlm.nih.gov/pubmed/36358625 http://dx.doi.org/10.3390/cancers14215206 |